Search

everythinglearnresearchcommunity

for

Search:↓

The FDA warned about safety issues with remdesivir and tofacitinib, finasteride is linked to suicidality, potent topical corticosteroids increase osteoporosis risk, henna can cause hemolysis in G6PD deficiency, chemotherapeutic agents can cause adverse reactions, drug interactions are common in cancer patients, ketamine can reduce at-risk drinking, high dose of anticholinergics increases dementia risk in Parkinson's patients, and prenatal exposure to second-generation antipsychotics increases pregnancy complications.

Some children with localized scleroderma are rarely resistant to methotrexate, and no common profile for resistance was found.

Chemotherapy reduces splenic melanin in mice.

Nutritional supplements may help improve hair growth in female pattern hair loss.

0.5% TPGS boosts hair growth with minoxidil, but 2% TPGS increases minoxidil absorption.

The new delivery system improves treatment for hair loss by enhancing drug absorption and effectiveness.

Non-coding RNA boosts retinoic acid production and signaling, aiding regeneration.

Chemotherapy provides symptom relief and extends life in 30-50% of gynecological cancer cases, but has only cured choriocarcinoma.

Treatment with dutasteride, minoxidil, and artificial hair transplantation improved appearance but caused folliculitis.

Mogamulizumab can cause hair loss, often linked to a better treatment response.

Loss of Dnmt3a and Dnmt3b increases aggressive skin tumors by affecting PPAR-γ.

Certain metabolites are lower in women with PCOS and could be potential markers for the condition.

Men with hair loss have more DNA changes in back-of-head hair follicles, possibly protecting them from thinning.

Etifoxine, an anxiety drug, can lessen brain inflammation and cognitive issues in mice, partly by increasing production of protective brain steroids.

The conclusion is that tritium-labeled testosterone metabolites can be made and are better converted into dihydrotestosterone in skin cells than in prostate tissue.

Inhibiting ALOX12 can help hair cuticle maturation by increasing S100A3 citrullination.

Two new compounds were found to effectively reduce hair growth in mice.

The new treatment was safe and may effectively treat male pattern hair loss.

Certain metabolites may help diagnose and predict polycystic ovary syndrome.

Retinoic acid and DMSO improve gene delivery to mouse skin for potential hair and skin disease treatment.

The new baby shampoo and wash with stearic acid is safe and potentially effective for nourishing babies' skin.

LAAM caused developmental toxicity in tolerant rats without causing birth defects.

New pregnane derivatives were more effective than finasteride at inhibiting a key enzyme for male pattern baldness.

A3B5 can reduce skin pigmentation and slow melanoma growth.

Human hair follicles can assess carcinogen metabolism and imidazole compounds might be effective anticarcinogens.

Bacopa procumbens extract may help protect the brain in Parkinson's disease.

Younger patients and those with more hair loss are less likely to benefit from oral steroid treatment for hair loss, and low vitamin D may predict relapse.

Most children with a common hemochromatosis genotype had elevated iron levels but no severe symptoms.

Certain microRNAs in the fluid around eggs are linked to Polycystic Ovary Syndrome and may help diagnose it.